Long-term efficacy and outcomes with sequential crizotinib followed by alectinib in ALK+ NSCLC
Autor: | Jochen K. Lennerz, Jessica J. Lin, Alice T. Shaw, Justin F. Gainor, Lorin A. Ferris, Satoshi Yoda, Beow Y. Yeap, Ibiayi Dagogo-Jack |
---|---|
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | Journal of Clinical Oncology. 36:9093-9093 |
ISSN: | 1527-7755 0732-183X |
Popis: | 9093Background: Alectinib was recently approved for first-line treatment of advanced ALK+ NSCLC based on the ALEX trial, which demonstrated improved PFS with first-line alectinib compared to crizot... |
Databáze: | OpenAIRE |
Externí odkaz: |